EGFR and non-small cell lung carcinoma: In total, 20 NSCLC patients (EGFR exon 19 deletion [n = 12] and EGFR wild-type [n = 8]) and 8 healthy controls were selected for further screening of candidate microRNAs correlating with EGFR exon 19 deletion mutation status.